miR-Test: A Blood Test for Lung Cancer Early Detection

Lung Cancer Screening With Low-Dose Computed Tomography: Costs, National Expenditures, and Cost-Effectiveness

(2017) Bernardo H. L. Goulart et al.   Journal of the National Comprehensive Cancer Network

Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study

(2014) Gabriella Sozzi et al.   JOURNAL OF CLINICAL ONCOLOGY

Cost-Effectiveness of CT Screening in the National Lung Screening Trial

(2014) William C. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lung-Cancer Screening with Low-Dose Computed Tomography

(2014) Michael K. Gould   NEW ENGLAND JOURNAL OF MEDICINE

Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer

(2013) Rom S. Leidner et al.   PLoS One

Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels

(2013) Heather H. Cheng et al.   PLoS One

Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer

(2012) Patrick T. Hennessey et al.   PLoS One

Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges

(2011) J. S. McDonald et al.   CLINICAL CHEMISTRY

A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer

(2011) Fabrizio Bianchi et al.   EMBO Molecular Medicine

Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer

(2011) Niels H.H. Heegaard et al.   INTERNATIONAL JOURNAL OF CANCER

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

(2011) Mattia Boeri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA biomarkers in lung cancer: MiRacle or quagMiRe?

(2011) Sai Yendamuri et al.   Translational Research

Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer

(2010) Zhibin Hu et al.   JOURNAL OF CLINICAL ONCOLOGY

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

(2010) Jun Shen et al.   LABORATORY INVESTIGATION

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)

(2010) Evan M. Kroh et al.   METHODS

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH

Lung cancer screening with low-dose computed tomography: A non-invasive diagnostic protocol for baseline lung nodules

(2008) Giulia Veronesi et al.   LUNG CANCER